{"id":57452,"date":"2023-05-22T19:03:03","date_gmt":"2023-05-22T17:03:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/"},"modified":"2023-05-22T19:03:03","modified_gmt":"2023-05-22T17:03:03","slug":"bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/","title":{"rendered":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nBuilds on success that resulted in BPGbio\u2019s first of its kind AI-guided prostate cancer test that distinguishes prostate cancer from benign prostatic hyperplasia (BPH)<\/li>\n<li>\nNew clinical development of a novel breast cancer diagnostic panel to \u201cupstage\u201d patients at time of diagnoses<\/li>\n<\/ul>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/aidrugdiscovery?src=hash\" target=\"_blank\" rel=\"noopener\">#aidrugdiscovery<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbpgbio.com%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=BPGbio&amp;index=1&amp;md5=60d7d80de2393540282201658f50f828\" rel=\"nofollow noopener\" shape=\"rect\">BPGbio<\/a>, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it will continue clinical validation of a novel breast cancer diagnostic panel that was developed under a previous agreement with the Department of Defense\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cbcp-research.org%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=Clinical+Breast+Care+Project&amp;index=2&amp;md5=8d99cc858d20ffe8ead0f8fc45cdc971\" rel=\"nofollow noopener\" shape=\"rect\">Clinical Breast Care Project<\/a> (CBCP), including the DoD\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.usuhs.edu%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=Uniformed+Services+University+of+the+Health+Sciences&amp;index=3&amp;md5=d662124c23aab67361a8bc343bcdc2c8\" rel=\"nofollow noopener\" shape=\"rect\">Uniformed Services University of the Health Sciences<\/a> (USU), <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.windbercare.org%2Ftag%2Fwindber-research-institute%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=The+Windber+Research+Institute&amp;index=4&amp;md5=9904b81859e4e05dc2320a863e6ec333\" rel=\"nofollow noopener\" shape=\"rect\">The Windber Research Institute<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hjf.org%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=The+Henry+M.+Jackson+Foundation&amp;index=5&amp;md5=fdbeb75cd1caa4a13e436891c94837fe\" rel=\"nofollow noopener\" shape=\"rect\">The Henry M. Jackson Foundation<\/a> for the Advancement of Military Medicine, Inc. (HJF). The new panel, developed with AI, is designed to identify women who are diagnosed with ER+ breast cancer but do not respond to hormone therapy, so that more effective options could be offered to improve treatment response.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/5\/BPGbio-logo-col-fnl1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg\"><\/a><\/p>\n<p>\nBPGbio\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbpgbio.com%2Fplatform%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=Interrogative+Biology&amp;index=6&amp;md5=ce914f552860df3191b47e99b2dafe95\" rel=\"nofollow noopener\" shape=\"rect\">Interrogative Biology<\/a>\u00ae Platform will complete comprehensive omics analysis and assessment using tissue and plasma\/serum samples from a CBCP-supported program focused on breast cancer research. The Interrogative Biology\u00ae Platform will also provide expanded assessment of BPGbio\u2019s novel breast cancer diagnostic 34 gene panel with a focus on ER+ breast cancers, which are significantly on the rise.<\/p>\n<p>\n\u201cWe are pleased to collaborate with BPGbio and use their AI and diagnostic platform to aid patients afflicted with breast cancer,\u201d said <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hjf.org%2Fleadership%2Fjoseph-caravalho-jr-md-mg-us-army-ret&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=Joseph+Caravalho&amp;index=7&amp;md5=da047a91f91993c47664b3b7ec47d0ac\" rel=\"nofollow noopener\" shape=\"rect\">Joseph Caravalho<\/a>, Jr., M.D., HJF\u2019s President and CEO. \u201cThe more treatment options offered earlier in the course of these diseases, the better the clinical outcomes will be. Breast cancer research is one of the many types of research that CBCP supports for those serving in uniform, and we know that innovations like BPGbio\u2019s platforms may greatly advance both military and civilian medicine.\u201d<\/p>\n<p>\nThe development of a novel diagnostic panel using AI as a non-invasive, non-PSA-based <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbpgbio.com%2Fprostate-health%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=prostate+cancer+screening+test&amp;index=8&amp;md5=d905ec3f9044dece678e414f9c20340f\" rel=\"nofollow noopener\" shape=\"rect\">prostate cancer screening test<\/a> began a few years ago. The diagnostic panel can distinguish prostate cancer from benign prostatic hyperplasia (BPH) individuals while also ruling out aggressive prostate cancers. This prevents the need for unnecessary biopsies in BPH men who inherently have elevated PSA. Now, a new panel will be used to screen breast cancer.<\/p>\n<p>\n\u201cWe are honored to work with CBCP and use BPGbio\u2019s Interrogative Biology<sup>\u00ae<\/sup> Platform to develop and validate another cancer diagnostic panel,\u201d said <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fniven-r-narain-448a606%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=Niven+R.+Narain&amp;index=9&amp;md5=c99e06186233047abd33813ba0f49c89\" rel=\"nofollow noopener\" shape=\"rect\">Niven R. Narain<\/a>, Ph.D., President and CEO of BPGbio. \u201cThe BPGbio team has exceptional expertise in translating comprehensive omics analysis into effective diagnostic products for various cancer indications, which improves the lives of the patients we serve.\u201d<\/p>\n<p>\n<b>About BPGbio, Inc.<\/b><\/p>\n<p>\nBPGbio, Inc., is a leading AI-powered, human-biology-centered biopharmaceutical company headquartered in the greater Boston, Massachusetts area. With its intelligent Interrogative Biology platform and the largest clinically annotated non-governmental biobank in the world, BPGbio is reimagining how patient biology can be modeled using unbiased AI to accelerate and de-risk the process of drug discovery across oncology, neurology, and rare diseases. For BPGbio therapeutics and diagnostics <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbpgbio.com%2Fpipeline%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=pipeline&amp;index=10&amp;md5=2b7c09662130249e83dd7c0384970561\" rel=\"nofollow noopener\" shape=\"rect\">pipeline<\/a>, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bpgbio.com&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=www.bpgbio.com&amp;index=11&amp;md5=c4d077f25cad31111ce7466f019fbdef\" rel=\"nofollow noopener\" shape=\"rect\">www.bpgbio.com<\/a><\/p>\n<p>\n<b>About HJF<\/b><\/p>\n<p>\nThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), now celebrating its 40th anniversary, is a global nonprofit organization with the mission to advance military medicine. HJF\u2019s scientific, administrative and program operations services empower investigators, clinicians, and medical researchers around the world to make discoveries in all areas of medicine. HJF serves as a trusted and responsive link between the military medical community, federal and private partners, and the millions of warfighters, veterans, and civilians who benefit from military medicine. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hjf.org%2F&amp;esheet=53403064&amp;newsitemid=20230518005580&amp;lan=en-US&amp;anchor=www.hjf.org.&amp;index=12&amp;md5=6b9403f543d330d999718a397e962f1f\" rel=\"nofollow noopener\" shape=\"rect\">www.hjf.org.<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia: <a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;M&#x65;&#x64;&#105;&#x61;&#64;&#x62;&#x70;&#103;&#x62;i&#x6f;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">Me&#100;&#105;&#x61;&#x40;&#x62;&#x70;gb&#105;&#111;&#x2e;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Builds on success that resulted in BPGbio\u2019s first of its kind AI-guided prostate cancer test that distinguishes prostate cancer from benign prostatic hyperplasia (BPH) New clinical development of a novel breast cancer diagnostic panel to \u201cupstage\u201d patients at time of diagnoses BOSTON&#8211;(BUSINESS WIRE)&#8211;#aidrugdiscovery&#8212;BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57452","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Builds on success that resulted in BPGbio\u2019s first of its kind AI-guided prostate cancer test that distinguishes prostate cancer from benign prostatic hyperplasia (BPH) New clinical development of a novel breast cancer diagnostic panel to \u201cupstage\u201d patients at time of diagnoses BOSTON&#8211;(BUSINESS WIRE)&#8211;#aidrugdiscovery&#8212;BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-22T17:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics\",\"datePublished\":\"2023-05-22T17:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/\"},\"wordCount\":617,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230518005580\\\/en\\\/1761793\\\/21\\\/BPGbio-logo-col-fnl1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/\",\"name\":\"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230518005580\\\/en\\\/1761793\\\/21\\\/BPGbio-logo-col-fnl1.jpg\",\"datePublished\":\"2023-05-22T17:03:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230518005580\\\/en\\\/1761793\\\/21\\\/BPGbio-logo-col-fnl1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230518005580\\\/en\\\/1761793\\\/21\\\/BPGbio-logo-col-fnl1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/","og_locale":"en_US","og_type":"article","og_title":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend","og_description":"Builds on success that resulted in BPGbio\u2019s first of its kind AI-guided prostate cancer test that distinguishes prostate cancer from benign prostatic hyperplasia (BPH) New clinical development of a novel breast cancer diagnostic panel to \u201cupstage\u201d patients at time of diagnoses BOSTON&#8211;(BUSINESS WIRE)&#8211;#aidrugdiscovery&#8212;BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-22T17:03:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics","datePublished":"2023-05-22T17:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/"},"wordCount":617,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/","url":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/","name":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg","datePublished":"2023-05-22T17:03:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230518005580\/en\/1761793\/21\/BPGbio-logo-col-fnl1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bpgbio-announces-new-partnership-with-dod-focused-on-ai-guided-breast-cancer-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57452"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57452\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}